Rules for EMR and EHR ROI from Michigan State Experience


By Cindy Atoji

August 5, 2008 | Nailing down ROI for electronic health records (EHRs) must be a deliberately thought-out process, says Michael H. Zaroukian, chief medical officer at Michigan State University (MSU), one of the early adopters of this technology. Zaroukian, who directed the EHR implementation at the MSU Internal Medicine Clinic, a community-based ambulatory care facility, says the 12-physician practice reaped major savings from a decline in paper chart pulls, staff costs, and transcription expenses.

“Simply putting an EHR system into place doesn’t give you return on investment (ROI), says Zaroukian. “EMRs that yield the most positive ROIs establish measurable financial outcomes at the start of the project.” Zaroukian spoke to Digital HealthCare & Productivity about the importance of tracking an implementation’s progress and avoiding the ROI-sapping effects of EMR customization.

DHP: You’ve said that “there is no free lunch for ROI.” What do you mean by this?

Zaroukian: If you take actions to improve quality, like putting in an EHR, you might expect cost savings, but it’s not automatic; it requires a cogent plan and striving to change processes in a way that decreases waste and increases efficiencies. The key is starting with the discipline to map your current processes in a paper world. Organizations, including ours, want to skip that—it’s hard and takes time, but if you don’t map out the current processes, you can’t get a handle on parts that are flawed or unnecessary. Be disciplined about process mapping and have a methodology for redesigning them.

If you focus on the few things that are measurable and then monitor the outcomes, your ability to achieve return on investment won’t be accidental, but deliberate. The good news is that if you look at improving quality of care, the natural consequence is that you will likely also see financial gains from that as well. For our ROI analysis we mainly looked at three things: decreasing chart pulls, eliminating transcription costs, and changing staff-to-physician ratio in a favorable manner.

DHP: What’s an example of a cost-benefit analysis that you performed?

Zaroukian: We needed a credible business case for this project, and when we looked at practice redesign and the various components of savings and cost, one of the things we looked at was paper chart pulls. We had a mathematically precise way of looking at this, because we have centralized medical records and allocated costs of $1.92 every time we wanted to pull a paper chart. We could predict on a basis of 3,500 chart pulls a month how much we could save by eliminating those.

After implementation, we monitored monthly paper chart pulls, which is one of the best indicators of adoption, and simply counting on a regular basis the number of paper chart pulls that are happening. By the time you’ve gotten down to 99 percent decrease in paper chart pulls, you must be [putting] everything in the EMR. We saw about a 90 percent decrease in first 8 or 9 months, which for faculty group practice is pretty fast. Over the course of the next few months, we were at 99 percent decrease in paper chart pulls, which for us was about an $87,000 savings per year.

We also monitored dictation cost and volume, as well as staff and labor costs, letting natural attrition take its place. The biggest cost for any clinic is staff costs. By improving staff-physician ratio, and not automatically replacing someone when they leave but evaluating whether a change is necessary, is an important discipline and a big difference between having a large return on investment versus not much of one at all.

DHP: One EHR expert says organizations are always trying to customize their EHR because they consider themselves “unique.” What do you do?

Zaroukian: We tried to spend time learning to be competent EMR users, more or less out of box, the way it comes, selecting from the options that are there, rather than focusing on customization or a lot of changes.

The phrase I tend to use is “customization is the enemy of implementation;” so you can customize or you can implement but you’ll have trouble doing both. Nothing is perfect, and you can personalize an EHR, which is different from customizing it. Personalization is the ability to say, “this is the way I like to document or work.” There are tools in most EHR systems that allow you to do that—narrative templates allow low-intensity personalization as well as quick text, or macros. Voice recognition is another way to personalize without having transcription costs.

DHP: Any other pitfalls of customization?

Zaroukian: The most expert person in leading customization should be a person highly experienced with the alternative. Because the notion that, “I know this form will work for me even though I’ve never used it” and “I want to design this new form, even though I’ve never used the new form,” in our experience has proven many times not to work.

Customizations come from experienced users, from a careful look at current process mapping, a deliberate storyboard approach to how the new customization would work [combined] with analysis of cost and benefit. We’ve spend many hundred of thousand of dollars on customizations at Michigan State University—and the same is true for many practices around the nation—for forms that have been never been used. That’s the definition of a complete waste of time.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Managed Innovation, Assured Compliance
Sponsored by SAS
Discovery organizations are identifying a lot of promising compounds, but clinical research processes haven't kept pace with timely testing of all those potential therapies. This white paper describes how SAS® Drug Development supports true innovation across the clinical trial process.

In this white paper you will learn how to:

  • Assemble data to foster better collaboration
  • Get up-to-date information during clinical trials
  • Make informed decisions earlier in the trial process


Addressing Life Sciences Constantly Growing Data Challenges Research Environments
Sponsored by BlueArc
The continued explosion of raw experimental data, the increased use of video, the growing adoption of new data retention practices, and the move to high throughput computational workflows are all placing new demands on the way life sciences organizations store and manage their data.

Download this white paper to learn about:

  • Factors driving the data explosion in the life sciences
  • New data management issues that must be addressed
  • HPC trends that are placing new demands on storage
  • Storage solution attributes that address performance, manageability, and energy efficiency.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms

Protocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required. More job detail is found at: http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at [email protected]. Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008. DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here

Related Resources & Products

Comparative Genomic Hybridization: Current State and Future Directions
Comparative Genomic Hybridization: Current State and Future Directions
State-by-State Clinical Trial Requirements Reference Guide 2006
Proteomics: Current State and Future Directions
Proteomics: Current State and Future Directions



For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to [email protected].